跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
斯耐瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bedaquiline Fumarate Tablets
Approved
化学药品
Bedaquiline Fumarate Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Sep 29, 2021
Approval ID
8BYtaTwj0SM
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8BYtaTwj0SM
Approval Number
国药准字HJ20171366
Generic Name
富马酸贝达喹啉片
Generic Name En
Bedaquiline Fumarate Tablets
Trade Name
斯耐瑞
Drug Type
化学药品
Dosage Form
片剂
Strength
100mg(以C₃₂H₃₁BrN₂O₂计)
Reg Date
2021-09-29
Expired Date
2026-09-28
Company Name
Janssen-Cilag International NV
Production Company Name
RECIPHARM PHARMASERVICES PRIVATE LIMITED
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/recipharm-pharmaservices-private-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 29, 2021
Approval ID
8BYtaTwj0SM
Type
化学药品
Back to NMPA Approvals